Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 67.25% |
| Q2 2025 | -1795.83% |
| Q1 2025 | -26.32% |
| Q4 2024 | -18.75% |
| Q3 2024 | 31.91% |
| Q2 2024 | -4.44% |
| Q1 2024 | 6.25% |
| Q4 2023 | -2.13% |
| Q3 2023 | -20.51% |
| Q2 2023 | 18.75% |
| Q1 2023 | -23.08% |
| Q4 2022 | 4.88% |
| Q3 2022 | 10.87% |
| Q2 2022 | -15.00% |
| Q1 2022 | 50.00% |
| Q4 2021 | 1.23% |
| Q3 2021 | 40.88% |
| Q2 2021 | -1145.45% |
| Q1 2021 | 21.43% |
| Q4 2020 | 51.72% |
| Q3 2020 | 47.27% |
| Q2 2020 | 27.63% |
| Q1 2020 | 94.80% |
| Q4 2019 | 69.96% |
| Q3 2019 | -102.25% |
| Q2 2019 | 6.20% |
| Q1 2019 | 15.49% |
| Q4 2018 | -37.29% |
| Q3 2018 | 18.75% |
| Q2 2018 | 17.38% |
| Q1 2018 | -4.84% |
| Q4 2017 | 1.88% |
| Q3 2017 | 15.72% |
| Q2 2017 | -28.32% |
| Q1 2017 | 0.00% |
| Q4 2015 | -61.75% |
| Q3 2015 | -0.55% |
| Q2 2015 | 52.76% |
| Q1 2015 | 0.00% |